查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679381

全球药用脂质辅料市场：市场规模、份额和趋势分析（按辅料类型、产品用途、疾病用途、行业用途、年龄组、最终用途和地区）、按细分市场预测（2025-2030 年）

Pharmaceutical Lipid-Based Excipients Market Size, Share & Trends Analysis Report By Excipient Type, By Product Applications, By Disease Application, By Industry Application, By Age Group, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 400 Pages | 商品交期: 2-10个工作天内

价格

药用脂质辅料市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球药用脂质辅料市场规模预计到2030年将达到24.2亿美元，预测期内的复合年增长率为4.8%。溶解性差的候选药物占候选药物管线的 87%，其数量的增加推动了先进辅料解决方案的采用。固体脂质奈米颗粒和自乳化药物传递系统等脂质基赋形剂对于复杂分子有效解决配方挑战至关重要。这种激增反映了製药业需要创新解决方案来提高药物的生物有效性和功效。

脂质辅料的整合彻底改变了 mRNA 疫苗和基因疗法，这在 COVID-19 大流行期间得到了突显。此外，主要药物的专利到期也进一步增加了对具有成本效益的辅料的需求。这些因素凸显了脂质辅料在现代药物开发中的变革性影响及其在推动药物传递创新中的作用。

人工智慧 (AI) 和配方技术的进步进一步促进了脂质辅料市场的成长。人工智慧主导的建模加速了基于脂质的配方，提高了可预测性并缩短了上市时间。监管机构对脂质辅料寄予厚望，透过关注纯度和安全特性将患者安全放在首位，最终确保药品品质和疗效。

药用脂质辅料市场：分析概述

  • 基于辅料，油脂辅料占据市场主导地位，占 2024 年总收入的 40.5%，这得益于脂质药物输送、营养保健品的使用和对永续成分的需求的进步。
  • 预测期内，卵磷脂和磷脂部分预计将以强劲的复合年增长率成长。
  • 根据产品应用，外用製剂将在 2024 年占据市场最大收益占有率，而眼科应用预计在预测期内以 6.7% 的最快速度增长。
  • 根据疾病，脂质辅料的肿瘤学应用将在 2024 年获得最大的收益。
  • 根据行业垂直性，膳食补充剂和其他部门预计将在预测期内实现最快的复合年增长率，这得益于脂质辅料製造商和专门从事补充剂的製药公司之间的战略伙伴关係关係。
  • 随着与老龄化相关的疾病变得越来越普遍，老年产品（65 岁及以上）部分预计在预测期内的复合年增长率将超过 5.0%。
  • 根据最终用途，预计製药商将在 2024 年成为市场的主要最终用户，占总收入的 64.9%。
  • 2024 年 4 月，IOI Oleo GmbH 为化妆品产业推出了 DYNASA CrystalCONTROL L。该产品解决了棒状配方中的「开花」效应，提高了产品稳定性和美观度，从而让全球的加工过程无忧无虑。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章製造商观点：市场驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
    • 市场机会分析
    • 市场问题分析
  • 药用脂质辅料市场：分析工具
    • 波特五力分析
  • 分析客户需求、问题和利益

第四章药用脂质辅料企业竞争格局

  • 公司/竞争对手分类（领先创新者、市场领导、新兴企业）
  • 脂质辅料製造商简介
    • ABITEC（ABF INGREDIENTS）.
    • BASF CORPORATION
    • GATTEFOSSE
    • CORDENPHARMA
    • LIPOID GMBH
    • IOI OLEO GMBH
    • CRODA INTERNATIONAL PLC
    • EVONIK INDUSTRIES AG
    • ASHLAND
    • MERCK KGAA
  • 公司市场占有率分析（2024 年）
  • 热图分析

第 5 章 最终使用者观点：市场驱动因素、趋势与范围

  • 药用脂质辅料市场展望：最终用户（购买者/消费者公司）的观点
    • 市场驱动因素分析
    • 市场机会分析
    • 市场限制分析
    • 市场问题分析
  • 分析药用脂质辅料市场的工具
    • 波特五力分析

第六章 终端使用者分析的竞争格局（买方/消费者企业）

  • 公司/竞争对手分类（领先创新者、市场领导、新兴企业）
  • 买家/消费者公司简介
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • VIATRIS INC.（FORMERLY MYLAN）
    • SANDOZ（A DIVISION OF NOVARTIS）
    • SUN PHARMACEUTICAL INDUSTRIES LTD.
    • CIPLA LTD.
    • DR. REDDY'S LABORATORIES LTD.
    • AUROBINDO PHARMA LTD.
    • LUPIN LTD.
    • ZYDUS LIFESCIENCES LTD.（FORMERLY CADILA）
    • HIKMA PHARMACEUTICALS PLC
  • Heatmap analysis

7. 药用脂质辅料市场按辅料类型划分（2018-2030 年）

  • 药用脂质辅料市场：依辅料类型分析
  • 依辅料类型（2018-2030 年）
    • 脂肪和油
    • 氢化植物油
    • GMCC
    • 硬脂
    • 中长链三酸甘油酯(MCTS)
    • 卵磷脂和磷脂
    • 油酸钠
    • 辛酸单双双酸甘油酯
    • 其他赋形剂类型

8. 药用脂质辅料市场依产品应用划分（2018-2030 年）

  • 药用脂质辅料市场：依产品应用分析
  • 依产品应用（2018-2030 年）
    • 口服製剂
    • 肠外
    • 局部应用程式
    • 眼科应用
    • 栓剂
    • 其他产品应用

9. 药用脂质辅料市场依疾病应用划分（2018-2030 年）

  • 药用脂质辅料市场：依疾病应用分析
  • 依疾病用途分类（2018-2030 年）
    • 心血管疾病
    • 神经系统疾病
    • 肿瘤学
    • 代谢紊乱
    • 荷尔蒙疗法
    • 感染疾病
    • 应用于其他疾病

10. 药用脂质辅料市场按产品产业划分（2018-2030 年）

  • 药用脂质辅料市场：依产品产业分析
  • 按产品产业（2018-2030 年）
    • 药品（OTC/RX）
    • 膳食补充剂（食品补充剂等）

11. 药用脂质辅料市场按年龄组别分類的产品状况（2018-2030 年）

  • 药用脂质辅料市场按年龄分類的产品
  • 各年龄层产品（2018-2030）
    • 儿童产品（0-18岁）
    • 成人用品（19-64岁）
    • 老年人产品（65岁以上）

12. 医药脂质辅料市场依最终用途划分（2018-2030 年）

  • 药用脂质辅料市场：最终用途产品分析
  • 依最终用途分类（2018-2030 年）
    • 製药商
    • 合约开发与製造组织 (CDMOS)
    • 其他的

第 13 章：药用脂质辅料市场：按地区分類的估计和趋势分析

  • 药用脂质辅料市场：区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 中国
    • 印度
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 约旦
    • 埃及
    • 伊朗
    • 科威特

第十四章 竞争格局

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 战略地图
    • 企业合併与收购 (M&A)
    • 伙伴关係和合作
    • 其他的
  • 公司简介
    • ABITEC Corporation
    • BASF
    • Gattefosse
    • CordenPharma
    • Lipoid
    • IOI Oleo GmbH
    • Croda International
    • Evonik Industries
    • Ashland
    • Merck KGaA
Product Code: GVR-4-68040-525-4

Pharmaceutical Lipid-based Excipients Market Growth & Trends:

The global pharmaceutical lipid-based excipients market size is anticipated to reach USD 2.42 billion by 2030 and is anticipated to expand at a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of poorly soluble drug candidates, representing 87% of pipeline candidates, has driven the adoption of advanced excipient solutions. Lipid-based excipients such as solid lipid nanoparticles and self-emulsifying drug delivery systems have become essential for complex molecules, addressing formulation challenges effectively. This surge reflects the pharmaceutical industry's need for innovative solutions to enhance drug bioavailability and efficacy.

The integration of lipid-based excipients has revolutionized mRNA vaccines and gene therapies, as highlighted during the COVID-19 pandemic. Moreover, the demand for cost-effective excipients has further increased due to patent expirations for major pharmaceutical drugs. These factors underscore the transformative impact of lipid excipients on modern pharmaceutical development and their role in driving innovation in drug delivery.

Advancements in artificial intelligence (AI) and formulation technologies further contribute to the growth of the lipid excipients market. AI-driven modeling accelerates lipid based formulations, enhancing predictability and reducing time-to-market. Regulatory bodies maintain high expectations for lipid excipients, prioritizing patient safety by focusing on purity and safety characteristics, ultimately ensuring the quality and effectiveness of pharmaceutical products.

Pharmaceutical Lipid-based Excipients Market Report Highlights:

  • Based on excipients, oil excipients dominated the market in 2024, accounting for 40.5% of the total revenue due to advancements in lipid drug delivery, nutraceutical use, and demand for sustainable ingredients.
  • The lecithin and phospholipids segment is projected to grow at a robust CAGR over the forecast period.
  • Based on product applications, topical formulations led the market with the largest revenue share in 2024; however, ophthalmic applications are expected to grow at the fastest rate of 6.7% over the forecast period.
  • Based on disease, oncological applications of lipid-based excipients garnered the largest revenue in 2024, aided by a growing pipeline of targeted therapies and immunotherapies for cancer.
  • Based on industry, the nutraceutical (dietary supplements & others) segment is expected to witness the fastest CAGR over the forecast period, fueled by strategic partnerships between lipid excipient manufacturers and supplement-focused pharmaceutical companies.
  • As aging-related conditions become more widespread, the geriatric products (65+ years) segment is expected to witness the fastest CAGR of over 5.0% over the forecast period.
  • Based on end use, pharmaceutical manufacturers emerged as dominant end users in the market in 2024, accounting for 64.9% of the total revenue.
  • In April 2024, IOI Oleo GmbH launched DYNASAN CrystalCONTROL L for the cosmetics industry. This product addresses the "blooming" effect in stick formulations, improving product stability and aesthetics for a worry-free process globally.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
    • 1.1.3 Objectives
    • 1.1.4 Objective - 1
    • 1.1.5 Objective - 2
    • 1.1.6 Objective - 3
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Market Evaluation Methodology:
  • 1.7 List Of Secondary Sources
  • 1.8 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot (Regional)
  • 2.2 Segment Snapshot (Excipient Type)
  • 2.3 Segment Snapshot (Product Application)
  • 2.4 Segment Snapshot (Disease Application)
  • 2.5 Segment Snapshot (Product Industry & Age-based Product)
  • 2.6 Segment Snapshot (Product Industry & Age-based Product)
  • 2.7 Segment Snapshot (End-use)
  • 2.8 Competitive Landscape

Chapter 3 Manufacturers Perspective: Market Variables, Trends, and Scope

  • 3.1 Pharmaceutical Lipid-Based Excipients Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
      • 3.1.1.1 Excipient Market
    • 3.1.2 Ancillary Market Outlook
      • 3.1.2.1 Polymers Excipient Market
      • 3.1.2.2 Sugars Excipient Market
      • 3.1.2.3 Minerals Excipient Market
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Proliferation of Drug Candidates with Low Water Solubility and Bioavailability Challenges
      • 3.2.1.2 Growing Application of Lipid Excipients in Biologics and RNA-based Therapeutics
      • 3.2.1.3 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
    • 3.2.2 Market Opportunities Analysis
      • 3.2.2.1 Expansion of Pharmaceutical Manufacturing in Emerging Markets as a Growth Opportunity for Lipid Excipients
      • 3.2.2.2 Growth of Local Manufacturers Enhancing Competition and Innovation in the Lipid Excipients Market
    • 3.2.3 Market Restraint Analysis
      • 3.2.3.1 Price Sensitivity in Emerging Markets Restricting the Adoption of Premium Lipid Excipients
      • 3.2.3.2 Market Dominance by Key Players Restricting Entry and Innovation in Lipid Excipients Sector
    • 3.2.4 Market Challenges Analysis
      • 3.2.4.1 Substantial R&D Investment Requirements for Developing Novel Lipid Excipients and Delivery Systems
      • 3.2.4.2 Global Regulatory and Compliance Complexities Adding Operational Challenges for Lipid Excipients Manufacturers
  • 3.3 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
    • 3.3.1 PORTER'S Five Forces Analysis
  • 3.4 Customer Needs, Pains, and Gains Analysis

Chapter 4 Manufacturers Competitive Landscape of Lipid-based Excipients

  • 4.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.2 Company Profiles for Manufacturers of Lipid Excipients
    • 4.2.1 ABITEC (ABF INGREDIENTS).
      • 4.2.1.1 Company Overview
      • 4.2.1.2 Financial Overview
      • 4.2.1.3 Product Overview
      • 4.2.1.4 Key Strategic initiatives
    • 4.2.2 BASF CORPORATION
      • 4.2.2.1 Company Overview
      • 4.2.2.2 Financial Overview
      • 4.2.2.3 Product Overview
      • 4.2.2.4 Strategic Initiatives
    • 4.2.3 GATTEFOSSE
      • 4.2.3.1 Company Overview
      • 4.2.3.2 Financial Overview
      • 4.2.3.3 Product Overview
      • 4.2.3.4 Strategic Initiatives
    • 4.2.4 CORDENPHARMA
      • 4.2.4.1 Company Overview
      • 4.2.4.2 Financial Overview
      • 4.2.4.3 Product Overview
      • 4.2.4.4 Strategic Initiatives
    • 4.2.5 LIPOID GMBH
      • 4.2.5.1 Company Overview
      • 4.2.5.2 Financial Overview
      • 4.2.5.3 product Overview
      • 4.2.5.4 Key Strategic Initiatives
    • 4.2.6 IOI OLEO GMBH
      • 4.2.6.1 Company overview
      • 4.2.6.2 Financial Overview
      • 4.2.6.3 Product Overview
      • 4.2.6.4 Strategic initiatives
    • 4.2.7 CRODA INTERNATIONAL PLC
      • 4.2.7.1 Company Overview
      • 4.2.7.2 Financial Overview
      • 4.2.7.3 Product Overview
      • 4.2.7.4 Strategic Initiatives
    • 4.2.8 EVONIK INDUSTRIES AG
      • 4.2.8.1 Company Overview
      • 4.2.8.2 Financial Overview
      • 4.2.8.3 Product Overview
      • 4.2.8.4 Strategic Initiatives
    • 4.2.9 ASHLAND
      • 4.2.9.1 Company Overview
      • 4.2.9.2 Financial Overview
      • 4.2.9.3 Product Overview
      • 4.2.9.4 Strategic Initiatives
    • 4.2.10 MERCK KGAA
      • 4.2.10.1 Company Overview
      • 4.2.10.2 Financial Overview: Thermo Fisher Scientific
      • 4.2.10.3 Product Overview
      • 4.2.10.4 Strategic Initiatives
  • 4.3 Company Market Share Analysis, 2024
  • 4.4 Heatmap analysis

Chapter 5 End User Perspective: Market Variables, Trends, and Scope

  • 5.1 Pharmaceutical Lipid-Based Excipients Market Outlook - End User (Buyer/Consumer Companies) Perspective
    • 5.1.1 Market Driver Analysis
      • 5.1.1.1 Innovation in formulation development
      • 5.1.1.2 End user companies are formulating drugs for pediatric, geriatric, and chronic disease markets
      • 5.1.1.3 The Influence of ESG Objectives on the Adoption of Sustainable Lipid Excipients by End Users
    • 5.1.2 Market Opportunities Analysis
      • 5.1.2.1 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
      • 5.1.2.2 Increasing prevalence of chronic diseases driving demand for lipid based formulations
    • 5.1.3 Market Restraint Analysis
      • 5.1.3.1 High R&D Costs, a Restraint for end use Pharmaceutical Companies Using Lipid-Based Excipients
      • 5.1.3.2 Regulatory Complexity
    • 5.1.4 Market Challenges Analysis
      • 5.1.4.1 Incompatibility with the active pharmaceutical ingredient (API)
      • 5.1.4.2 Stability and Shelf-Life Concerns
  • 5.2 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
    • 5.2.1 PORTER'S Five Forces Analysis

Chapter 6 End User Analysis (Buyer/Consumer Companies) Competitive Landscape

  • 6.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.2 Buyer/Consumer Company Profiles
    • 6.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • 6.2.1.1 Company Overview
      • 6.2.1.2 Financial Overview
      • 6.2.1.3 Product Overview
      • 6.2.1.4 Key Strategic initiatives
    • 6.2.2 VIATRIS INC. (FORMERLY MYLAN)
      • 6.2.2.1 Company Overview
      • 6.2.2.2 Financial Overview
      • 6.2.2.3 PRODUCT OVERVIEW
      • 6.2.2.4 Strategic Initiatives
    • 6.2.3 SANDOZ (A DIVISION OF NOVARTIS)
      • 6.2.3.1 Company Overview
      • 6.2.3.2 Financial Overview
      • 6.2.3.3 Product Overview
    • 6.2.4 SUN PHARMACEUTICAL INDUSTRIES LTD.
      • 6.2.4.1 Company Overview
      • 6.2.4.2 Financial Overview
      • 6.2.4.3 Product Overview
    • 6.2.5 CIPLA LTD.
      • 6.2.5.1 Company Overview
      • 6.2.5.2 Financial Overview
      • 6.2.5.3 product Overview
      • 6.2.5.4 Key Strategic Initiatives
    • 6.2.6 DR. REDDY'S LABORATORIES LTD.
      • 6.2.6.1 Company overview
      • 6.2.6.2 Financial Overview
      • 6.2.6.3 Product Overview
      • 6.2.6.4 Strategic initiatives
    • 6.2.7 AUROBINDO PHARMA LTD.
      • 6.2.7.1 Company Overview
      • 6.2.7.2 Financial Overview
      • 6.2.7.3 Product Overview
      • 6.2.7.4 Strategic Initiatives
    • 6.2.8 LUPIN LTD.
      • 6.2.8.1 Company Overview
      • 6.2.8.2 Financial Overview
      • 6.2.8.3 Product Overview
    • 6.2.9 ZYDUS LIFESCIENCES LTD. (FORMERLY CADILA)
      • 6.2.9.1 Company Overview
      • 6.2.9.2 Financial Overview
      • 6.2.9.3 Product Overview
      • 6.2.9.4 Strategic Initiatives
    • 6.2.10 HIKMA PHARMACEUTICALS PLC
      • 6.2.10.1 Company Overview
      • 6.2.10.2 Financial Overview: Hikma Pharmaceuticals PLC
      • 6.2.10.3 Product Overview
  • 6.3 Heatmap analysis

Chapter 7 Pharmaceutical Lipid-Based Excipients Market, By Excipient Type, 2018 - 2030 (USD Million)

  • 7.1 Pharmaceutical Lipid-Based Excipients Market: Excipient Type Analysis
  • 7.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Excipient Type, 2018 - 2030 (USD Million)
    • 7.2.1 Oils
      • 7.2.1.1 Sesame Oil
      • 7.2.1.2 Soybean Oil
      • 7.2.1.3 Sunflower Oil
      • 7.2.1.4 Linseed Oil /Flaxseed Oil
      • 7.2.1.5 Safflower Oil
      • 7.2.1.6 Coconut Oil
      • 7.2.1.7 Arachis Oil / Peanut Oil
      • 7.2.1.8 Corn Oil / Maize Oil
      • 7.2.1.9 Olive Oil
      • 7.2.1.10 Almond Oil
      • 7.2.1.11 Castor Oil
      • 7.2.1.12 Cotton Seed Oil
      • 7.2.1.13 Grapeseed Oil
      • 7.2.1.14 Other Oils
    • 7.2.2 Hydrogenated Vegetable Oils
    • 7.2.3 GMCC
    • 7.2.4 Hard Fats
    • 7.2.5 Medium Chain Triglycerides (MCTS)
    • 7.2.6 Lecithin And Phospholipids
    • 7.2.7 Sodium Oleate
    • 7.2.8 Capri Caprylic Mono Diglyceride
    • 7.2.9 Other Excipient Types

Chapter 8 Pharmaceutical Lipid-Based Excipients Market, By Product Applications, 2018 - 2030 (USD Million)

  • 8.1 Pharmaceutical Lipid-Based Excipients Market: Product Application Analysis
  • 8.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Application, 2018 - 2030 (USD Million)
    • 8.2.1 Oral Formulations
      • 8.2.1.1 Softgel Capsules
      • 8.2.1.2 Solid Dosage
      • 8.2.1.3 Liquid Oral
      • 8.2.1.4 Solid Lipid Nanoparticles (Slns)
    • 8.2.2 Parenteral
      • 8.2.2.1 Small Volume Parenteral
      • 8.2.2.2 Large Volume Parenteral
    • 8.2.3 Topical Applications
      • 8.2.3.1 Creams
      • 8.2.3.2 Ointments
      • 8.2.3.3 Other Topical Applications
    • 8.2.4 Ophthalmic Applications
      • 8.2.4.1 Eye Drops
      • 8.2.4.2 Ocular Emulsions
    • 8.2.5 Suppositories
      • 8.2.5.1 Rectal Suppositories
      • 8.2.5.2 Vaginal Suppositories
      • 8.2.5.3 Other Suppositories
    • 8.2.6 Other Product Applications

Chapter 9 Pharmaceutical Lipid-Based Excipients Market, By Disease Application, 2018 - 2030 (USD Million)

  • 9.1 Pharmaceutical Lipid-Based Excipients Market: Disease Application Analysis
  • 9.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Disease Application, 2018 - 2030 (USD Million)
    • 9.2.1 Cardiovascular Diseases
    • 9.2.2 Neurological Disorders
    • 9.2.3 Oncology
    • 9.2.4 Metabolic Disorders
    • 9.2.5 Hormonal Therapies
    • 9.2.6 Infectious Diseases
    • 9.2.7 Other Disease Applications

Chapter 10 Pharmaceutical Lipid-Based Excipients Market, By Product Industry, 2018 - 2030 (USD Million)

  • 10.1 Pharmaceutical Lipid-Based Excipients Market: Product Industry Analysis
  • 10.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Industry, 2018 - 2030 (USD Million)
    • 10.2.1 Pharmaceutical (OTC & RX)
    • 10.2.2 Nutraceutical (Dietary Supplements & Other)

Chapter 11 Pharmaceutical Lipid-Based Excipients Market, By Age-Based Product, 2018 - 2030 (USD Million)

  • 11.1 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product Analysis
  • 11.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Age-Based Product, 2018 - 2030 (USD Million)
    • 11.2.1 Pediatric Products (0-18 Years)
    • 11.2.2 Adult Products (19-64 Years)
    • 11.2.3 Geriatric Products (65+ Years)

Chapter 12 Pharmaceutical Lipid-Based Excipients Market, By End-Use, 2018 - 2030 (USD Million)

  • 12.1 Pharmaceutical Lipid-Based Excipients Market: End-Use Product Analysis
  • 12.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by End-Use, 2018 - 2030 (USD Million)
    • 12.2.1 Pharmaceutical Manufacturers
    • 12.2.2 Contract Development And Manufacturing Organizations (CDMOS)
    • 12.2.3 Other

Chapter 13 Pharmaceutical Lipid-Based Excipients Market: Regional Estimates and Trend Analysis

  • 13.1 Pharmaceutical Lipid-Based Excipients Market: Regional Outlook
  • 13.2 North America
    • 13.2.1 North America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.2.2 U.S.
      • 13.2.2.1 Key Country Dynamics
      • 13.2.2.2 U.S. Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 13.2.2.3 Competitive/Market Scenario
      • 13.2.2.4 Regulatory Framework
    • 13.2.3 Canada
      • 13.2.3.1 Key Country Dynamics
      • 13.2.3.2 Canada Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 13.2.3.3 Competitive/Market Scenario
      • 13.2.3.4 Regulatory Framework
    • 13.2.4 Mexico
      • 13.2.4.1 Key Country Dynamics
      • 13.2.4.2 Mexico Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.2.4.3 Competitive/Market Scenario
      • 13.2.4.4 Regulatory Framework
  • 13.3 Europe
    • 13.3.1 Europe Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.3.2 UK
      • 13.3.2.1 Key Country Dynamics
      • 13.3.2.2 UK pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.2.3 Competitive/Market Scenario
      • 13.3.2.4 Regulatory Framework
    • 13.3.3 Germany
      • 13.3.3.1 Key Country Dynamics
      • 13.3.3.2 Germany pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.3.3 Competitive/Market Scenario
      • 13.3.3.4 Regulatory Framework
    • 13.3.4 France
      • 13.3.4.1 Key Country Dynamics
      • 13.3.4.2 France pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.4.3 Competitive/Market Scenario
      • 13.3.4.4 Regulatory Framework
    • 13.3.5 Italy
      • 13.3.5.1 Key Country Dynamics
      • 13.3.5.2 Italy pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.5.3 Competitive/Market Scenario
      • 13.3.5.4 Regulatory Framework
    • 13.3.6 Spain
      • 13.3.6.1 Key Country Dynamics
      • 13.3.6.2 Spain pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.6.3 Competitive/Market Scenario
      • 13.3.6.4 Regulatory Framework
    • 13.3.7 Norway
      • 13.3.7.1 Key Country Dynamics
      • 13.3.7.2 Norway Pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.7.3 Competitive/Market Scenario
      • 13.3.7.4 Regulatory Framework
    • 13.3.8 Sweden
      • 13.3.8.1 Key Country Dynamics
      • 13.3.8.2 Sweden pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.8.3 Competitive/Market Scenario
      • 13.3.8.4 Regulatory Framework
    • 13.3.9 Denmark
      • 13.3.9.1 Key Country Dynamics
      • 13.3.9.2 Denmark Pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
      • 13.3.9.3 Competitive/Market Scenario
      • 13.3.9.4 Regulatory Framework
    • 13.3.10 Rest Of Europe Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.4 Asia Pacific
    • 13.4.1 Asia Pacific Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.4.2 China
      • 13.4.2.1 Key Country Dynamics
      • 13.4.2.2 China pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.4.2.3 Competitive/Market Scenario
      • 13.4.2.4 Regulatory Framework
    • 13.4.3 India
      • 13.4.3.1 Key Country Dynamics
      • 13.4.3.2 India pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.4.3.3 Competitive/Market Scenario
      • 13.4.3.4 Regulatory Framework
    • 13.4.4 South Korea
      • 13.4.4.1 Key Country Dynamics
      • 13.4.4.2 South Korea pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.4.4.3 Competitive/Market Scenario
      • 13.4.4.4 Regulatory Framework
    • 13.4.5 Rest Of Asia Pacific Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.5 Latin America
    • 13.5.1 Latin America Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.5.2 Brazil
      • 13.5.2.1 Key Country Dynamics
      • 13.5.2.2 Brazil pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.5.2.3 Competitive/Market Scenario
      • 13.5.2.4 Regulatory Framework
    • 13.5.3 Argentina
      • 13.5.3.1 Key Country Dynamics
      • 13.5.3.2 Argentina pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.5.3.3 Competitive/Market Scenario
      • 13.5.3.4 Regulatory Framework
    • 13.5.4 Rest Of Latin America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.6 MEA
    • 13.6.1 MEA Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.6.2 South Africa
      • 13.6.2.1 Key Country Dynamics
      • 13.6.2.2 South Africa Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.2.3 Competitive/Market Scenario
      • 13.6.2.4 Regulatory Framework
    • 13.6.3 Saudi Arabia
      • 13.6.3.1 Key Country Dynamics
      • 13.6.3.2 Saudi Arabia pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.3.3 Competitive/Market Scenario
      • 13.6.3.4 Regulatory Framework
    • 13.6.4 UAE
      • 13.6.4.1 Key Country Dynamics
      • 13.6.4.2 UAE pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.4.3 Competitive/Market Scenario
      • 13.6.4.4 Regulatory Framework
    • 13.6.5 Jordan
      • 13.6.5.1 Key Country Dynamics
      • 13.6.5.2 Jordan pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.5.3 Competitive/Market Scenario
      • 13.6.5.4 Regulatory Framework
    • 13.6.6 Egypt
      • 13.6.6.1 Key Country Dynamics
      • 13.6.6.2 Egypt pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.6.3 Competitive/Market Scenario
      • 13.6.6.4 Regulatory Framework
    • 13.6.7 Iran
      • 13.6.7.1 Key Country Dynamics
      • 13.6.7.2 Iran pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.7.3 Competitive/Market Scenario
      • 13.6.7.4 Regulatory Framework
    • 13.6.8 Kuwait
      • 13.6.8.1 Key Country Dynamics
      • 13.6.8.2 Kuwait pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.8.3 Competitive/Market Scenario
      • 13.6.8.4 Regulatory Framework
    • 13.6.9 Rest Of MEA Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 14 Competitive Landscape

  • 14.1. Market Participant Categorization
  • 14.2. Company Market Position Analysis/ Heap Map Analysis
  • 14.3. Strategy Mapping
    • 14.3.1. Mergers & Acquisitions
    • 14.3.2. Partnerships & Collaborations
    • 14.3.3. Others
  • 14.4. Company Profiles
    • 14.4.1. ABITEC Corporation
    • 14.4.2. BASF
    • 14.4.3. Gattefosse
    • 14.4.4. CordenPharma
    • 14.4.5. Lipoid
    • 14.4.6. IOI Oleo GmbH
    • 14.4.7. Croda International
    • 14.4.8. Evonik Industries
    • 14.4.9. Ashland
    • 14.4.10. Merck KGaA

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Company market share, 2024
  • Table 4. Projected number of adults 50 years and older with chronic disease in the U.S. (in Million)
  • Table 5. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by excipient type, 2018 - 2030 (USD Million)
  • Table 6. Oil excipient market analysis
  • Table 7. Sesame oil excipient market analysis
  • Table 8. Soybean excipient market analysis
  • Table 9. Sunflower excipient market analysis
  • Table 10. Linseed oil /flaxseed oil excipient market analysis
  • Table 11. Safflower oil excipient market analysis
  • Table 12. Coconut oil excipient market analysis
  • Table 13. Peanut oil excipient market analysis
  • Table 14. Corn oil/ maize oil excipient market analysis
  • Table 15. Olive oil excipient market analysis
  • Table 16. Almond oil excipient market analysis
  • Table 17. Castor oil excipient market analysis
  • Table 18. Cotton seed oil excipient market analysis
  • Table 19. Grape seed oil excipient market analysis
  • Table 20. Cotton seed oil excipient market analysis
  • Table 21. Hydrogenated vegetable oils excipient market analysis
  • Table 22. GMCC excipient market analysis
  • Table 23. Hard fat vegetable oils excipient market analysis
  • Table 24. MCT excipient market analysis
  • Table 25. Lecithin and phospholipids excipient market analysis
  • Table 26. Sodium oleate excipient market analysis
  • Table 27. Capri caprylic mono diglyceride excipient market analysis
  • Table 28. Other types excipient market analysis
  • Table 29. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product application, 2018 - 2030 (USD Million)
  • Table 30. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by Disease application, 2018 - 2030 (USD Million)
  • Table 31. Global heart & circulatory disease prevalence in 2021 and deaths 2021
  • Table 32. Global risk factors for heart & circulatory diseases (CVD)
  • Table 33. Alzheimer's disease prevalence in various countries
  • Table 34. Parkinson's disease prevalence in various countries
  • Table 35. New cases and deaths for 36 cancers and all cancers combined in 2022
  • Table 36. Incidence and mortality rates (age-standardized rate per 100,000, cumulative risk) for 24 world areas and by sex for all cancers combined (including nonmelanoma skin cancer except basal cell carcinoma) in 2022.
  • Table 37. Estimated number, percentage, and awareness of prediabetes among adults aged 18 years or older, U.S., 2017 - 2020 and 2021
  • Table 38. Global diabetes data report 2000 - 2045
  • Table 39. Prevalence of some of the endocrine disorders in 2022
  • Table 40. Global and regional estimates of TB incidence, numbers (in thousands) and rates (per 100 000 population) in 2023
  • Table 41. Global and regional estimates of TB mortality, numbers (in thousands) and rates (per 100 000 population) in 2023
  • Table 42. Subgroup analysis of the prevalence of Dry Eye Disorder in Asia
  • Table 43. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product industry, 2018 - 2030 (USD Million)
  • Table 44. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by age-based product, 2018 - 2030 (USD Million)
  • Table 45. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by end-use, 2018 - 2030 (USD Million)
  • Table 46. Key lipid excipients manufacturers in the U.S.
  • Table 47. Key end user of lipid excipients in the U.S.
  • Table 48. Key lipid excipients manufacturers in the Canada
  • Table 49. Key end user of lipid excipients in the Canada
  • Table 50. Key lipid excipients manufacturers in the Mexico
  • Table 51. Key end user of lipid excipients in the Mexico
  • Table 52. Key lipid excipients manufacturers in the UK
  • Table 53. Key end user of lipid excipients in the UK
  • Table 54. Key lipid excipients manufacturers in the Germany
  • Table 55. Key end user of lipid excipients in the Germany
  • Table 56. Key lipid excipients manufacturers in the France
  • Table 57. Key end user of lipid excipients in the France
  • Table 58. Key lipid excipients manufacturers in Itay.
  • Table 59. Key End users of lipid excipients in Italy
  • Table 60. Key lipid excipients manufacturers in Spain.
  • Table 61. Key End users of lipid excipients in Spain
  • Table 62. Key lipid excipients manufacturers in the Norway.
  • Table 63. Key End users of lipid excipients in the Norway
  • Table 64. Key lipid excipients manufacturers in Sweden.
  • Table 65. Key End users of lipid excipients in Sweden
  • Table 66. Key lipid excipients manufacturers in Denmark.
  • Table 67. Key End users of lipid excipients in Denmark
  • Table 68. Key lipid excipients manufacturers in China.
  • Table 69. Key End users of lipid excipients in China
  • Table 70. Key lipid excipients manufacturers in India.
  • Table 71. Key End users of lipid excipients in India
  • Table 72. Key lipid excipients manufacturers in the South Korea
  • Table 73. Key end user of lipid excipients in the South Korea
  • Table 74. Key lipid excipients manufacturers in Brazil.
  • Table 75. Key End users of lipid excipients in Brazil
  • Table 76. Key lipid excipients manufacturers in Argentina.
  • Table 77. Key End users of lipid excipients in Argentina
  • Table 78. Key lipid excipients manufacturers in South Africa.
  • Table 79. Key End users of lipid excipients in South Africa
  • Table 80. Key lipid excipients manufacturers in Saudi Arabia.
  • Table 81. Key End users of lipid excipients in Saudi Arabia
  • Table 82. Key lipid excipients manufacturers in UAE.
  • Table 83. Key End users of lipid excipients in UAE
  • Table 84. Key lipid excipients manufacturers in Jordan.
  • Table 85. Key End users of lipid excipients in Jordan
  • Table 86. Key lipid excipients manufacturers in Egypt.
  • Table 87. Key End users of lipid excipients in Egypt
  • Table 88. Key lipid excipients manufacturers in Iran.
  • Table 89. Key End users of lipid excipients in Iran
  • Table 90. Key End users of lipid excipients in Kuwait

List of Figures

  • Fig. 1 Pharmaceutical lipid-based excipients market: Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot (Excipient type)
  • Fig. 10 Segment snapshot (Product Application)
  • Fig. 11 Segment snapshot (Disease Application)
  • Fig. 12 Segment snapshot (Product industry & age-based product)
  • Fig. 13 Segment snapshot (Product industry & age-based product)
  • Fig. 14 Segment snapshot (End-use)
  • Fig. 15 Competitive landscape
  • Fig. 16 Excipients market estimates and forecast, 2018-2030, USD Million
  • Fig. 17 Market dynamics
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • Fig. 20 Company market share analysis, 2024
  • Fig. 21 Heatmap analysis
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • Fig. 24 Heatmap analysis
  • Fig. 25 Pharmaceutical Lipid-Based Excipients Market: Excipient Type outlook and key takeaways
  • Fig. 26 Pharmaceutical Lipid-Based Excipients Market: Excipient type movement analysis
  • Fig. 27 Oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Sesame oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Soybean oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Sunflower oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Linseed oil /flaxseed oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Safflower oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Coconut oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Arachis oil / peanut oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Corn oil / maize oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Olive oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Almond oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Castor oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Grapeseed oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Other oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Hydrogenated vegetable oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 GMCC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hard fats market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Medium Chain triglycerides (MCTs) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Lecithin and phospholipids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Sodium oleate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Capri caprylic mono diglyceride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Other excipient types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Pharmaceutical Lipid-Based Excipients Market: Product Application outlook and key takeaways
  • Fig. 50 Pharmaceutical Lipid-Based Excipients Market: Product application movement analysis
  • Fig. 51 Oral formulations market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Softgel capsules market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Solid dosage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Small volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Large volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Topical applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Creams market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Other topical applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Ophthalmic applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Ocular emulsions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Rectal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Vaginal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Other Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Other product applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Pharmaceutical Lipid-Based Excipients Market: Disease Application outlook and key takeaways
  • Fig. 72 Pharmaceutical Lipid-Based Excipients Market: Disease Application movement analysis
  • Fig. 73 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Hormonal therapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Other disease applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Pharmaceutical Lipid-Based Excipients Market Product Industry outlook and key takeaways
  • Fig. 81 Pharmaceutical Lipid-Based Excipients Market: Product Industry movement analysis
  • Fig. 82 Pharmaceutical (OTC & Rx) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Nutraceutical (dietary supplements & other) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Pharmaceutical Lipid-Based Excipients Market Age-Based Product outlook and key takeaways
  • Fig. 85 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product movement analysis
  • Fig. 86 Pediatric products (0-18 years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Adult products (19-64 years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Geriatric products (65+ years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Pharmaceutical Lipid-Based Excipients Market End-Use outlook and key takeaways
  • Fig. 90 Pharmaceutical Lipid-Based Excipients Market: End-Use Product movement analysis
  • Fig. 91 Pharmaceutical manufacturers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Contract Development and Manufacturing Organizations (CDMOs) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Pharmaceutical Lipid-Based Excipients Market, revenue, by region, 2024 & 2030 (USD million)
  • Fig. 95 Regional marketplace: Key takeaways
  • Fig. 96 Regional marketplace: Key takeaways
  • Fig. 97 North America pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 U.S. pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Canada pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Mexico pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030, USD Million
  • Fig. 104 Europe pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UK pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Germany pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 France pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Italy pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 Spain pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Norway pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Sweden pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Denmark pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Rest of Europe pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Asia Pacific pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 123 Key country dynamics
  • Fig. 124 China pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Key country dynamics
  • Fig. 126 India pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Key country dynamics
  • Fig. 128 South Korea pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Rest of Asia Pacific pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 130 Latin America pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 131 Key country dynamics
  • Fig. 132 Brazil pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Key country dynamics
  • Fig. 134 Argentina pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 135 Rest of Latin America pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 136 MEA pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 137 Key country dynamics
  • Fig. 138 South Africa pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 139 Key country dynamics
  • Fig. 140 Saudi Arabia pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 141 Key country dynamics
  • Fig. 142 UAE pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 143 Key country dynamics
  • Fig. 144 Jordan pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 145 Key country dynamics
  • Fig. 146 Egypt pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 147 Key country dynamics
  • Fig. 148 Iran pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 149 Key country dynamics
  • Fig. 150 Kuwait pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 151 Rest of MEA pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)